GATD3A

Across TCGA pan-cancer cohorts, GATD3A RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated GATD3A data layer compared with 1 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher GATD3A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GATD3A expression acts as an unfavorable survival marker, although some lineages such as UCS and BLCA show a favorable association.

STAD, ACC, and UCS are the cancer types where GATD3A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.240	0.458	.005	51	view →
ACC	DFS	Median	III,IV	0.282	0.598	.005	46	view →
UCS	DFS	Tertile	II,III,IV	0.693	0.160	.001	42	view →
BLCA	OS	Median	All	0.771	0.598	.012	36	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	32	view →
CESC	DFS	Median	II,III,IV	0.697	0.860	.009	28	view →
UVM	OS	Median	All	0.434	0.929	.021	14	view →
KIRC	OS	Quartile	All	0.741	0.532	.003	12	view →
LIHC	OS	Median	All	0.674	0.441	.010	11	view →
ESCA	OS	Median	All	1.000	0.449	.011	11	view →
LUAD	DFS	Quartile	II,III,IV	0.529	0.816	.004	10	view →
PAAD	OS	Quartile	II,III,IV	0.800	0.458	.006	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

GATD3A–STAD (DFS)

Open the STAD breakdown →